Results 121 to 130 of about 3,216,105 (293)

Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers : the Nordic example [PDF]

, 2018
RMD Open 2018;4:e000655.
Aaltonen, Kalle, Askling, Johan, Chatzidionysiou, Katerina, Di Giuseppe, Daniela, Dreyer, Lene, Frisell, Thomas, Glintborg, Bente, Guðbjörnsson, Bjorn, Hellgren, Karin, Hetland, Merete Lund, Jacobsson, Lennart, Jørgensen, Tanja Schjødt, Kristensen, Lars Erik, Kristianslund, Eirik Klami, Kvien, Tore K., Nordström, Dan, Provan, Sella A., Törmänen, Minna R.K.   +17 more
core   +2 more sources

Malignancies and immunoglobulin G4‐related disease

Rheumatology &Autoimmunity, EarlyView.
Immunoglobulin G4‐related disease (IgG4‐RD) is associated with increased cancer risk. Malignancies affect both IgG4‐RD involved organs, such as the lung, pancreas, bile duct, and prostate, and noninvolved organs, such as the gastrointestinal duct. B‐cell neoplasms constitute a proportion of the malignancies linked to this disease.
Jingna Li, Wen Zhang
wiley   +1 more source

Variations in criteria regulating treatment with reimbursed biologic DMARDs across European countries : are differences related to country's wealth? [PDF]

, 2014
Objectives: To explore criteria regulating treatment with reimbursed biologic disease-modifying antirheumatic drugs (bDMARDs) in patients with rheumatoid arthritis (RA) across Europe and to relate criteria to indicators of national socioeconomic welfare.
Boonen, Annelies, Equity in Clinical Eligibility Criteria for RA treatment Working group, on behalf of, Kvien, Tore K, Mielants, Herman, Putrik, Polina, Ramiro, Sofia, Sokka, Tuulikki, Uhlig, Till   +7 more
core   +2 more sources

Trial of a new antirheumatic agent.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1974
A double-blind crossover trial of fenoprofen calcium versus acetylsalicylic acid (aspirin) and placebo in 10 outpatients with active rheumatoid arthritis, is reported. Both fenoprofen and aspirin were found to be similarly effective agents in rheumatoid arthritis with an average dose of 2,1 g fenoprofen compared with 4,5 g aspirin.
openaire   +3 more sources

Effects of psoriatic arthritis‐targeted drugs on bone remodeling: Clinical evidence and molecular pathways

Rheumatology &Autoimmunity, EarlyView.
Mechanisms and therapeutic targets in psoriatic arthritis: balancing inflammatory bone resorption and bone formation. Abstract Psoriatic arthritis (PsA) is a chronic inflammatory disease characterized by diverse clinical manifestations. Of particular concern, osteopenia and osteoporosis are prevalent in 45.27% and 12.94% of PsA patients, respectively ...
Yingchao Sun, Cheng Xu, Mingli Ouyang, Yongmei Han   +3 more
wiley   +1 more source

Periodontal Indices in Patients with Rheumatoid Arthritis Undergoing Immunosuppressive Therapy [PDF]

مجله دانشگاه علوم پزشکی گرگان
Background and Objective: Periodontitis and rheumatoid arthritis are two chronic inflammatory diseases that are interrelated. Given the similarities between these conditions, the medications used by patients with rheumatoid arthritis (RA) may affect ...
Ilnaz Frahoudi, Afsaneh Enteshari-Moghaddam, Zakiyeh Movahedzadeh   +2 more
doaj  

Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab. [PDF]

, 2019
Purpose: The objectives of this study were to evaluate and compare treatment patterns and infusion-related health care resource expenditures for rheumatoid arthritis (RA) patients initiating golimumab for intravenous use (GLM-IV) and infliximab (IFX ...
DeHoratius, Raphael J., Ellis, Lorie A., Kafka, Shelly, Kubacki, Maureen, Malangone-Monaco, Elisabetta, Stetsovsky, Diana, Varker, Helen   +6 more
core   +1 more source

Mannose Oligosaccharide‐Conjugated In Situ Pore‐Forming Injectable Hydrogels for Rheumatoid Arthritis Treatment by Reprogramming Macrophage Extracellular Vesicles

Small Methods, EarlyView.
Design of an injectable porous hydrogel modulating macrophages and their secreted EVs for joint defect repair in the pathology of rheumatoid arthritis. a) The solution containing HA and CS‐MOS, upon mixing with a crosslinker solution, undergoes porous hydrogel formation with the escape of generated CO₂ gas.
Anan Zhang, Yifan Ma, Yutong Liu, Shiyan Dong, Michelle Najarro Torres, Betty Y.S. Kim, Changsheng Liu, Lili Sun, Yuan Yuan, Wen Jiang   +9 more
wiley   +1 more source

The Methotrexate Story: How did a Cancer Chemotherapeutic Agent Become a Disease-modifying Antirheumatic Drug

, 2023
Anand N. Malaviya, Astha Sareen
openalex   +1 more source

Adherence to United European Gastroenterology Guidelines on Diagnosis and Therapy of Immunoglobulin‐G4‐Related Digestive Disease

United European Gastroenterology Journal, EarlyView.
ABSTRACT Introduction United European Gastroenterology (UEG) Guidelines on immunoglobulin G4 (IgG4)‐related digestive disease provides evidence‐based recommendations for the diagnosis and management of IgG4‐related digestive disease. The aim of this study is to evaluate the adherence to recommendations of this IgG4 guideline across centers in Europe ...
Miroslav Vujasinovic, Marco Lanzillotta, Emma L. Culver, Vinciane Rebours, Joost P. H. Drenth, Milica Stojkovic Lalosevic, Jens Vikse, Natalya Gubergrits, Michael Hirth, Vincenzo Cardinale, Rodrigo Vieira Motta, Emanuel Della‐Torre, Nicole Sciberras, Marcello Maida, Artemis Trikola, Frank Lammert, Clemence Descourvières, Cyriel Ponsioen, Jens Brøndum Frøkjær, Alexander Schneider, Domenico Alvaro, Gabriele Capurso, J.‐Matthias Löhr   +22 more
wiley   +1 more source